Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA, CMS Coordination On Coverage Decisions May Improve Under McClellan

This article was originally published in The Gray Sheet

Executive Summary

FDA and the Centers for Medicare & Medicaid Services are likely to have a closer relationship under the tenure of incoming commissioner Mark McClellan, MD/PhD

You may also be interested in...



FDA Review Criteria Are Insufficient To Prompt CMS Coverage – Feigal, Tunis

Proposals allowing FDA's approval criteria to play a greater role in Medicare coverage determinations should account for the fact that many devices are cleared via 510(k) and not reviewed for clinical effectiveness, CDRH Director David Feigal asserted Oct. 11

FDA Review Criteria Are Insufficient To Prompt CMS Coverage – Feigal, Tunis

Proposals allowing FDA's approval criteria to play a greater role in Medicare coverage determinations should account for the fact that many devices are cleared via 510(k) and not reviewed for clinical effectiveness, CDRH Director David Feigal asserted Oct. 11

McClellan FDA Commissioner Nomination Likely On Senate Fast Track

The Senate Health, Education, Labor & Pensions Committee appears to be fast-tracking the confirmation process for FDA Commissioner-nominee Mark McClellan, MD/PhD

Latest News
See All
UsernamePublicRestriction

Register

MT017298

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel